trial summary · NCT07497321
Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)
Trial record from the TrialBase DB dataset, status RECRUITING, condition Pelvic Organ Prolapse (POP), sponsored by A.M.I. Agency for Medical Innovations GmbH. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The purpose of this clinical investigation is to collect clinical data about the ProGYNious Mesh based on a prospective clinical investigation. The primary objective is to verify the treatment outcome and success of the ProGYNious mesh implant in pelvic organ prolapse repair. The secondary objective is to confirm the safety, risks, complications and quality of life of ProGYNious as an implant for pelvic organ prolapse repair.
Source record: https://clinicaltrials.gov/study/NCT07497321
Facts
| registry id | NCT07497321 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Pelvic Organ Prolapse (POP) |
| sponsor | A.M.I. Agency for Medical Innovations GmbH |
| sponsor class | INDUSTRY |
| enrollment | 100 |
| start date | 2026-10-28 |
| primary completion | 2028-12-31 |
| completion | 2029-03-31 |
| results posted | not reported |
Conditions
- Pelvic Organ Prolapse (POP)
- Synthetic Mesh
- Laparoscopic Surgery
- Gynecologic Laparoscopic Surgery
- Sacrocolpopexy
- Pelvic Floor Prolapse
- Pelvic Floor
- Implant
Interventions
- Surgical mesh for pelvic organ prolapse repair (ProGYNious)
Countries
- Austria
- Germany
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.